Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/42922
Title: NMR in drug discovery. From screening to structure-based design of antitumoral agents
Author: Rodríguez Mías, Ricard Aleix
Director: Giralt Lledó, Ernest
Keywords: Oncologia
Farmacologia
RMN
Ressonància magnètica nuclear
Issue Date: 5-Oct-2006
Publisher: Universitat de Barcelona
Abstract: [eng] Nuclear Magnetic Resonance has experienced an increasing interest in the drug discovery field that has led to its wide use on nearly every stage of drug development. For this reason, during the present thesis we propose to use some of the tools offered by NMR to target various systems related with cancer. Initially we intended to get acquainted with the NMR most outstanding methodologies for the detection and characterization of binding events; and for this goal various proteins involved in cellular apoptosis (XIAP and Bcl-XL) were used to set up both ligand and receptor based NMR experiments. First we developed two novel labeling methodologies for the selective NMR observation of Trp, which coupled to the use of receptor-based experiments provided insight in the characterization of XIAP-ligand complexes, as well as significant advantages for HTS. Later, ligand based experiments such as STD, WaterLOGSY and iLOE were applied to the screening of weak binders for Bcl-XL, and the resulting information applied to the reconstruction of dual binders in a fragment-based drug discovery approach. In a second stage the same NMR tools were applied to the development of protein-protein interaction inhibitors, in particular for the pro-angiogenic protein VEGF; and to this end two different strategies were proposed. First, a small diverse library of D-oligopeptides was screened for weak ligands using the former fragment-based strategy. A second approach consisted on the identification of active compounds in complex plant extract mixtures using a combination of methionine selective labeling schemes and receptor-based experiments. In the latter case various flavonoids were identified as VEGF binders and the information harvested from NMR experiments allowed us to propose a binding mode for this type of molecules. Lastly, in a much more classic context, we decided to attempt the characterization of a medium sized oligopeptide by NMR. In particular we focused on Kahalalide F a marine origin depsipeptide with very promising anticancer activity; and although a SAR profile would be very useful from a medicinal chemistry perspective such molecules still pose a challenge to their structural characterization particularly stemming from its intrinsic flexibility. Several media were explored including H2O, DMSO, and membrane mimics (SDS micelles); in the latter the peptide seems to adopt a preferred structure allowing us to propose a model for the monomeric insertion of Kahalalide F within membrane-like environments. Such a model supports that part of the peptide's cytotoxic activity occurs at a membrane level and that this activity is linked to the formation of a turn within its N-terminus section.
[spa] La resonancia magnética nuclear se utiliza en la actualidad en prácticamente todas las etapas del proceso de descubrimiento y caracterización de fármacos. Durante la presente tesis nos propusimos explorar estas facetas de la RMN tomando como modelo diferentes sistemas relacionados con cáncer. En primer lugar utilizamos proteínas involucradas en apoptosis (XIAP y Bcl-XL) para implementar varias metodologías de RMN para la caracterización de fenómenos de interacción intermolecular. Se pusieron a punto esquemas de marcaje selectivo de triptófano y se evaluó su aplicabilidad en procesos de cribado de compuestos. Otros experimentos de cribado masivo (STD, WaterLOGSY) se emplearon para identificar nuevos ligandos de Bcl-XL; posteriormente, estrategias de reconstrucción de fragmentos nos permitieron diseñar ligandos duales. Las mismas herramientas se utilizaron para el diseño y desarrollo de moléculas antiangiogénicas, inhibidoras de la interacción entre VEGF y sus receptores. Para este fin, se plantearon dos estrategias diferentes en la identificación de inhibidores: en primer lugar se pretendía diseñar un ligando peptídico de afinidad elevada partiendo de dipéptidos de menor afinidad y utilizando estrategias de reconstrucción de fragmentos. Una segunda estrategia consistía en la identificación de compuestos activos presentes en extractos de plantas utilizando esquemas de marcaje selectivo para VEGF, en concreto marcaje selectivo de metioninas. En este último caso se consiguieron identificar varios compuestos flavonoides capaces de interaccionar con VEGF y su modo de unión se caracterizó utilizando información derivada de experimentos de RMN. Por último se llevo a cabo la caracterización estructural de Kahalalido F mediante RMN. Este depsipéptido de origen marino se encuentra en la actualidad en fases clínicas de desarrollo contra varios tipos de cáncer, y su caracterización estructural presenta enorme interés en la comprensión de su modo de acción. Se exploraron las preferencias conformacionales del péptido en varios medios incluyendo: H2O, DMSO, y medios miméticos de membrana (micelas SDS). El péptido adopta una estructura preferente en presencia de micelas de SDS, lo que nos permiten proponer un modelo estructural para la inserción monomérica de Kahalalido F en entornos de membrana lipídica; esto sugiere que parte de su actividad citotóxica ocurre a nivel de membrana para lo cual la formación de un giro  en la sección N-terminal del péptido también parece relevante.
URI: http://hdl.handle.net/2445/42922
ISBN: 9788469049709
Appears in Collections:Tesis Doctorals - Departament - Química Orgànica

Files in This Item:
File Description SizeFormat 
01.RARM_Introduction_objectives.pdf433.35 kBAdobe PDFView/Open
02.RARM_Chapter_1.pdf1.35 MBAdobe PDFView/Open
03.RARM_Chapter_2.pdf1.82 MBAdobe PDFView/Open
04.RARM_Chapter_3.pdf1.24 MBAdobe PDFView/Open
05.RARM_Conclusions_Materials_Methods.pdf198.14 kBAdobe PDFView/Open
06.RARM_Resumen.pdf224.25 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.